Altered fractionation in radiation therapy for squamous-cell carcinoma of the head and neck.

Abstract:

:Following is a review of altered fractionation in radiation therapy for head and neck cancer. The goals of altered fractionation are to increase local-regional control and/or reduce the risk of late complications. Altered fractionation schedules can be broadly classified as accelerated fractionation and hyperfractionation. Data indicate that some of these schedules, particularly hyperfractionated radiation therapy, offer improved results compared to conventionally fractionated radiation therapy. Most investigators have observed no significant increased risk of late complications with the dose-fractionation schedules described.

journal_name

Cancer Invest

journal_title

Cancer investigation

authors

Mendenhall WM,Parsons JT

doi

10.3109/07357909809032890

subject

Has Abstract

pub_date

1998-01-01 00:00:00

pages

594-603

issue

8

eissn

0735-7907

issn

1532-4192

journal_volume

16

pub_type

杂志文章,评审
  • Quinacrine Depletes BCR-ABL and Suppresses Ph-Positive Leukemia Cells.

    abstract::Drug resistance to TKIs and the existance of CML leukemia stem cells is an urgent problem. In this study, we demonstrate that quinacrine (QC) induces apoptosis in BCR-ABL positive CML and acute lymphoblastic leukemia (ALL) cells. Interestingly, QC inhibits the colony formation of primary CD34+ progenitor/stem leukemia...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2019.1630633

    authors: Lei H,Tu Y,Yang L,Jin J,Luo H,Xu H,Kang J,Zhou L,Wu Y

    更新日期:2019-01-01 00:00:00

  • A Review of Quality of Life Measures used in Surgical Outcomes for Stage I Lung Cancers.

    abstract::This review summarizes the literature on QoL in early stage lung cancer patients who underwent surgery. PubMed and PsycINFO were searched. Twelve articles from 10 distinct studies were identified for a total of 992 patients. Five QoL measures were used. One study reported only on pre-surgical QoL, six only on post-sur...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357907.2018.1474892

    authors: Yip R,Taioli E,Schwartz R,Li K,Becker BJ,Tam K,Htwe YM,Yankelevitz DF,Henschke CI

    更新日期:2018-01-01 00:00:00

  • A double-blind, randomized study of two different dosage regimens of intravenous dolasetron in patients receiving high-dose cisplatin chemotherapy.

    abstract::This study compared the antiemetic efficacy and safety of two different intravenous (i.v.) dolasetron dosing regimens in patients receiving their first course of high-dose (> or = 80 mg/m2) cisplatin. Of 30 patients enrolled, 14 received a single i.v. dolasetron dose (0.6 mg/kg) before cisplatin and 16 received a mult...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.3109/07357909709039730

    authors: Kasimis BS,Tapazoglou E,Schulman P,Stewart WH,Hahne WF,Cramer MB

    更新日期:1997-01-01 00:00:00

  • Intensity modulated arc therapy in bilaterally irradiated head and neck cancer: a comparative and prospective multicenter planning study.

    abstract::A dosimetric comparison was made of Helical Tomotherapy (HT) and Rapid'Arc(®) (RA) in 115 patients with head and neck carcinoma included in a prospective and multicentric study. HT and RA provided highly conformal plans that easily complied with dose volume constraints for organs at risk. HT reduced high doses to the ...

    journal_title:Cancer investigation

    pub_type: 杂志文章,多中心研究

    doi:10.3109/07357907.2014.889705

    authors: Vernat SS,Ali D,Messina C,Pommier P,Dussart S,Puyraveau M,Viard R,Lacornerie T,Lisbona A,Fenoglietto P,Mazurier J,Garcia R,Hangard G,Zefkili S,Makovicka L,Giraud P

    更新日期:2014-06-01 00:00:00

  • Cochleovestibular toxicity related to dichloromethotrexate.

    abstract::A 69-year-old man receiving monotherapy for lung cancer with dichloromethotrexate (DCM), and without exposure to other chemotherapeutic agents or known ototoxic drugs, developed profound cochleovestibular dysfunction. The initial presentation was vestibular. This resolved, but unilateral hearing loss ensued and contin...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908909039861

    authors: Golden L,Ahlgren JD,Kattah J,Smith JW,Sisk R,Deeb Z

    更新日期:1989-01-01 00:00:00

  • Trends in Survival Based on Treatment Modality in Non-Small Cell Lung Cancer Patients: A Population-Based Study.

    abstract::Objectives: We examined the trends in survival based on treatment modality among non-small cell lung cancer (NSCLC) patients in the province of Ontario, Canada, from 2007 to 2015. Methods: We investigated the trends in survival based on treatment modality. Results: Among 56,417 identified patients, the mean age at dia...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2019.1653465

    authors: Akhtar-Danesh N,Akhtar-Danseh GG,Seow HY,Shakeel S,Finley C

    更新日期:2019-01-01 00:00:00

  • The prognostic impact of bone marrow micrometastases in women with breast cancer.

    abstract::Metastasis is the overwhelming cause of mortality in patients with breast cancer and our understanding of its cellular and molecular determinants is limited. Among cellular determinants, disseminated (DTC) tumor cells undoubtedly are key players in the metastatic cascade. In the past, several models have been construc...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357900802574496

    authors: Braun S,Auer D,Marth C

    更新日期:2009-07-01 00:00:00

  • Overexpression of glucose transporter-1 (GLUT-1) predicts poor prognosis in epithelial ovarian cancer.

    abstract::Illumina microarray was used to identify differentially expressed genes in three epithelial ovarian cancer (EOC) cells. To validate the microarray data, mRNA and protein level of glucose transporter-1 (GLUT-1) was examined. GLUT-1 had an EOC/normal cells ratio of 5.51 based on microarray. Real-time PCR and immunohisto...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2013.849722

    authors: Cho H,Lee YS,Kim J,Chung JY,Kim JH

    更新日期:2013-11-01 00:00:00

  • Anti-angiogenic treatment of gastrointestinal malignancies.

    abstract::The scientific rationale to block angiogenesis as a treatment strategy for human cancer has been developed over the last 30 years, but is only now entering the clinical arena. Preclinical studies have demonstrated the importance of the vascular endothelial growth factor (VEGF) pathways in both physiologic and patholog...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357900500360024

    authors: Salmon JS,Lockhart AC,Berlin J

    更新日期:2005-01-01 00:00:00

  • Antitumor and Antiangiogenic Activities of Lenvatinib in Mouse Xenograft Models of Vascular Endothelial Growth Factor-Induced Hypervascular Human Hepatocellular Carcinoma.

    abstract::High expression of vascular endothelial growth factor (VEGF) in patients with hepatocellular carcinoma (HCC) is associated with poor prognosis. Here, we investigated the antitumor activity of lenvatinib, a multiple receptor tyrosine kinase inhibitor, in VEGF-overexpressing HCC models. In human umbilical vein endotheli...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2019.1601209

    authors: Adachi Y,Matsuki M,Watanabe H,Takase K,Kodama K,Matsui J,Funahashi Y,Nomoto K

    更新日期:2019-01-01 00:00:00

  • Thrombin expression in prostate: a novel finding.

    abstract:INTRODUCTION:A variable repertoire of coagulation protein expression is observed in different cancers. We evaluated expression of thrombin in prostate tissue. METHODS:Detection of thrombin was performed using quantitative real-time PCR in fresh tissue and in situ hybridization (ISH) in archival prostate tissue and by ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2010.535057

    authors: Kohli M,Williams K,Yao JL,Dennis RA,Huang J,Reeder J,Ricke WA

    更新日期:2011-01-01 00:00:00

  • MicroRNA-138 Regulates DNA Damage Response in Small Cell Lung Cancer Cells by Directly Targeting H2AX.

    abstract::Lung cancer is the leading cause of cancer death worldwide and small cell lung cancer (SCLC) accounts for a significant proportion of all lung cancer cases. Even so, the underlying mechanism governing SCLC development remains poorly understood and SCLC related cancer death stands high despite decades of intensive inve...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2015.1006329

    authors: Yang H,Luo J,Liu Z,Zhou R,Luo H

    更新日期:2015-04-01 00:00:00

  • A phase I trial to determine the safety of imatinib in combination with vatalanib in patients with advanced malignancies.

    abstract::The role of tyrosine kinase inhibitors (TKIs) in the treatment of advanced malignancies is well established. Imatinib and vatalanib are oral TKIs with different mechanisms of action. This trial sought to establish the safety, tolerability, and maximum tolerated dose (MTD) of the two agents in combination. Secondary ob...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2011.568567

    authors: Spigel D,Jones S,Hainsworth J,Infante J,Greco FA,Thompson D,Doss H,Burris H

    更新日期:2011-05-01 00:00:00

  • In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosis.

    abstract::In vivo and in vitro observations of cellular immune response in 70 patients with squamous cell cancer of the oral cavity and in 40 age-matched normal controls, were made using delayed hypersensitivity responses to DNCB, PPD, and Candida albicans extract (Dermatophytin 'O'), absolute lymphocyte counts, absolute T-cell...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908609018450

    authors: Das SN,Khanna NN,Khanna S

    更新日期:1986-01-01 00:00:00

  • Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: report of two cases and review of literature.

    abstract::Placement of carmustine-impregnated wafers has become a common practice after surgical resection of malignant gliomas. Bevacizumab is used as a second-line agent for the treatment of malignant gliomas and is sometimes used in patients who have had recent wafer implantation. We describe two cases of fatal cerebrospinal...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357907.2010.483499

    authors: Nagaiah G,Almubarak M,Khan M,Altaha R

    更新日期:2010-12-01 00:00:00

  • Telomere biology of pediatric cancer.

    abstract::One of the hallmarks of cancer is limitless proliferative capacity, which is tightly associated with the ability to maintain telomeres. Over the last decade, the telomere biology of pediatric cancers has begun to be elucidated. Most pediatric leukemias and embryonal solid tumors activate the enzyme telomerase, a speci...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357900701208683

    authors: Tabori U,Dome JS

    更新日期:2007-04-01 00:00:00

  • IGF1R-targeted therapy and its enhancement of doxorubicin chemosensitivity in human osteosarcoma cell lines.

    abstract::Type-I insulin-like growth factor receptor (IGF1R) and its signaling play an important role in osteosarcomagenesis, tumor progression, and chemoresistance. The purpose of this study was to investigate both the effect and mechanisms of IGF1R inhibition by tyrphostin AG1024 in the presence or absence of doxorubicin in a...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2011.606252

    authors: Luk F,Yu Y,Walsh WR,Yang JL

    更新日期:2011-10-01 00:00:00

  • The role of NF-kappaB in Hepatitis b virus X protein-mediated upregulation of VEGF and MMPs.

    abstract::Hepatitis B virus X protein (HBx) promotes hepatocellular carcinoma (HCC) invasion and metastasis by a poorly understood mechanism. This study investigated the role of NF-kappa B in HBx-mediated upregulation of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs). In a stably expressing HBx c...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357900903405959

    authors: Liu LP,Liang HF,Chen XP,Zhang WG,Yang SL,Xu T,Ren L

    更新日期:2010-06-01 00:00:00

  • The Roles of Tissue Rigidity and Its Underlying Mechanisms in Promoting Tumor Growth.

    abstract::Tissues become more rigid during tumorigenesis and have been identified as a driving factor for tumor growth. Here, we highlight the concept of tissue rigidity, contributing factors that increase tissue rigidity, and mechanisms that promote tumor growth initiated by increased tissue rigidity. Various factors lead to i...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357907.2020.1802474

    authors: Zakaria MA,Rajab NF,Chua EW,Selvarajah GT,Masre SF

    更新日期:2020-09-01 00:00:00

  • Investigation of Human Cytomegalovirus and Human Papillomavirus in Glioma.

    abstract::The study investigated the human cytomegalovirus (HCMV) and human papillomavirus (HPV) in gliomas. A retrospective study was conducted on 112 samples. HCMV was investigated by PCR, in situ hybridization (ISH) and immunohistochemistry. HPV was tested by PCR and DNA ISH. HCMV was identified in 60 gliomas, including 55 G...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2020.1793352

    authors: Limam S,Missaoui N,Hmissa S,Yacoubi MT,Krifa H,Mokni M,Selmi B

    更新日期:2020-08-01 00:00:00

  • Managing patients and families at the ending of life: hospice assumptions, structures, and practice in response to staff stress.

    abstract::Hospice programs do not identify burnout as a significant staff problem, even though there are many significant stressors for staff members doing hospice work. Hospices offer support in a wide variety of ways and settings through their human resources management. All this support is predicated on the assumption that t...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909709039724

    authors: Brenner PR

    更新日期:1997-01-01 00:00:00

  • 5-Fluorouracil and high-dose calcium leucovorin for hepatocellular carcinoma: a phase II trial.

    abstract::A phase II trial of 5-fluorouracil (5-FU) [250-450 mg/m2/day x 5 days as an intravenous (IV) bolus] combined with calcium leucovorin (500 mg/m2/day x 5 1/2 days by continuous IV infusion) administered on a 28-day schedule was performed in 15 patients with advanced hepatocellular carcinoma. The median age was 58 years;...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909509024907

    authors: Tetef M,Doroshow J,Akman S,Coluzzi P,Leong L,Margolin K,Morgan RJ Jr,Raschko J,Shibata S,Somlo G

    更新日期:1995-01-01 00:00:00

  • A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer.

    abstract:BACKGROUND:Premenopausal women treated for early stage breast cancer (ESBC) are at risk for chemotherapy-related amenorrhea (CRA). Prospectively-validated, predictive markers of CRA are needed. PATIENTS AND METHODS:Premenopausal women with ESBC and planned chemotherapy (>/= 25% risk of amenorrhea) were evaluated. Foll...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900701829777

    authors: Anders C,Marcom PK,Peterson B,Gu L,Unruhe S,Welch R,Lyons P,Behera M,Copland S,Kimmick G,Shaw H,Snyder S,Antenos M,Woodruff T,Blackwell K

    更新日期:2008-04-01 00:00:00

  • Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP.

    abstract::Enhanced proteolysis and altered tight junction (TJ) proteins associate with carcinoma invasion. We hypothesized that trypsin-2, a tumor-associated serine proteinase, induces tongue carcinoma invasion by activating pro-membrane type-1 matrix metalloproteinase (MT1-MMP) and disturbing the TJs. The effects of invasion w...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2012.716467

    authors: Vilen ST,Suojanen J,Salas F,Risteli J,Ylipalosaari M,Itkonen O,Koistinen H,Baumann M,Stenman UH,Sorsa T,Salo T,Nyberg P

    更新日期:2012-10-01 00:00:00

  • Conventional versus high-dose epidoxorubicin as single agent in advanced breast cancer.

    abstract::Between March 1986 and December 1987, two groups of consecutive patients with advanced breast cancer underwent epidoxorubicin (Epidx) monochemotherapy. Twenty-three patients (group A) received Epidx at a dose of 60 mg/m2 and 27 (group B) at a dose of 120 mg/m2 (i.v. every 3 weeks). No patient had undergone anthracycli...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909309024827

    authors: Neri B,Pacini P,Algeri R,Lottini G,Rinaldini M,Tucci E,Pusterla R

    更新日期:1993-01-01 00:00:00

  • Mutational status of codons 12 and 13 of the N- and K-ras genes in tissue and cell lines derived from primary and metastatic prostate carcinomas.

    abstract::N- and K-ras mutations at codons 12 and 13 were investigated using oligonucleotide hybridization analysis after PCR amplification and subsequent sequence analysis of the amplified DNA from the region of interest in the following prostatic primary and metastatic (met) carcinoma-derived cell lines: 1013L (primary), PC3 ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909309020257

    authors: Pergolizzi RG,Kreis W,Rottach C,Susin M,Broome JD

    更新日期:1993-01-01 00:00:00

  • A phase I trial of chlorambucil administered in short pulses in patients with advanced malignancies.

    abstract::We carried out a phase I trial with chlorambucil. Thirty patients with advanced cancer were entered in six dose levels: 36, 48, 60, 84, 108, and 144 mg/m2. The drug was given in six divided oral doses every 6 hours and the regimen was repeated every 3 weeks. The median age was 62 years (31-84), median Karnofsky perfor...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908809080064

    authors: Blumenreich MS,Woodcock TM,Sherrill EJ,Richman SP,Gentile PS,Epremian BE,Kubota TT,Allegra JC

    更新日期:1988-01-01 00:00:00

  • Tumor suppressor proteins are differentially affected in human ependymoblastoma and medulloblastoma cells exposed to nerve growth factor.

    abstract::The aim of our study was to investigate the role of nerve growth factor (NGF) on the expression of the p73 protein in human ependymoblastoma (EP) and medulloblastoma (MB) cells. It was found that NGF exposure on MB cells blocks proliferation, as well as on EP cells and induces overexpression of p73. NGF reduces the nu...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900701205689

    authors: Antonelli A,Lenzi L,Nakagawara A,Osaki T,Chiaretti A,Aloe L

    更新日期:2007-03-01 00:00:00

  • BMP4 is involved in the chemoresistance of myeloid leukemia cells through regulating autophagy-apoptosis balance.

    abstract::This study showed that silencing BMP4 expression significantly activated caspase-2, 3, and 9, while decreasing Matrigel colony formation in Cytarabine (Ara-C)-treated leukemia HL-60 cells. In contrast, Ara-C significantly upregulated Atg5 and Beclin-1 expression, the ratio of LC3-II/LC3-I, and CDK1 and cyclin B1 expre...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2013.834925

    authors: Zhao X,Liu J,Peng M,Liu J,Chen F

    更新日期:2013-10-01 00:00:00

  • Differential expression of Kv1.3 and Kv1.5 voltage-dependent K+ channels in human skeletal muscle sarcomas.

    abstract::Because Kv1.3 and Kv1.5 K(+) channels are remodeled during tumorigenesis and participate in skeletal muscle proliferation, we analyzed their expression in human skeletal muscle sarcomas. Aggressive alveolar rhabdomyosarcoma (ARMS) and embryonal rhabdomyosarcoma (ERMS) were studied. Kv1.5 expression was moderate in adu...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2012.654872

    authors: Bielanska J,Hernández-Losa J,Moline T,Somoza R,Ramón y Cajal S,Condom E,Ferreres JC,Felipe A

    更新日期:2012-03-01 00:00:00